LAMTOR5 and ovarian carcinoma: In this study, we postulate that HBXIP may be used as a tumor marker, combined with clinical symptoms and signs, to detect high-risk groups and to improve the early clinical diagnosis of ovarian cancer, which may be have distinct value.